SCHEMBL6494367

SCHEMBL6494367

CN(C)c1ccc(/C=C/c2nccn2C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
CASP1 P29466 2/20 0.54
HBB P68871 2/20 0.54
ALOX15 P16050 1/20 0.54
RELA Q04206 1/20 0.49
APP P05067 4/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
GFER P55789 2/20 0.46
KDM4E B2RXH2 2/20 0.46
S100A4 P26447 1/20 0.44
GAA P10253 1/20 0.44
BRCA1 P38398 1/20 0.44
CASP7 P55210 1/20 0.44
PTGS1 P23219 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494371 1.00 MAPT (0.54) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL6208429 0.81 NFE2L2 (0.42) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL6208431 0.81 NFE2L2 (0.42) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL6208862 0.80 NPC1 (0.48) MAPTKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6208861 0.80 NPC1 (0.48) MAPTKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL2457803 0.80 KDM4E (0.47) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL2457805 0.80 KDM4E (0.47) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL15871029 0.78 LPO (0.48) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL1476241 0.75 TBXAS1 (0.45) MAPTMEN1KMT2ASMN1; SMN2ALOX15
SCHEMBL20843890 0.75 MEN1 (0.56) MAPTMEN1KMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP MAPT 7/4885MEN1 3565/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.